Abstract
Dupuytren’s disease (DD) is characterized by the progressive development of a scar-like collagen-rich cord within the palmar fascia of the hand that results in permanent finger contracture. Currently, DD is most commonly treated by surgical resection of the diseased tissue. To date, no directly analogous animal model has been described in which to evaluate potential nonsurgical treatments for Dupuytren’s contracture. In the present study, we endeavor to establish an animal model that may ultimately serve as a platform in which to compare various treatments for DD. Hypothesizing that fibroblasts are the cellular effectors of the Dupuytren’s phenotype, we have transplanted fibroblasts derived from DD palmar fascia into the forepaw of nude rats. Our initial examinations showed that DD-derived fibroblasts persisted successfully in the forepaws of nude rats up to 56 days. Initial studies with quantitative real-time RT-PCR (qRT-PCR) using RNA derived from forepaw tissues harvested at 8 weeks showed that mRNA levels of alpha-smooth muscle actin (α-SMA) and type I collagen were significantly elevated in the forepaws of nude rats injected with DD-derived fibroblasts. The increase in α-SMA suggests an in vivo fibroblast to myofibroblast transformation that ultimately may result in scar formation and contracture.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Alioto RJ, Rosier RN, Burton RI, Puzas JE (1994) Comparative effects of growth factors on fibroblasts of Dupuytren’s tissue and normal palmar fascia. J Hand Surg [Am] 19:442–452
Badalamente MA, Hurst LC (2007) Efficacy and safety of injectable missed collagenase subtypes in the treatment of Dupuytren’s contracture. J Hand Surg [Am] 32:767–774
Badalamente MA, Sampson SP, Hurst LC, Dowd A, Miyasaka K (1996) The role of transforming growth factor-beta in Dupuytren’s disease. J Hand Surg [Am] 21:210–215
Baird KS, Crossan JF, Ralston SH (1993) Abnormal growth factor and cytokine expression in Dupuytren’s contracture. J Clin Pathol 46:425–428
Bisson MA, McGrouther DA, Mudera V, Grobbelaar AO (2003) The different characteristics of Dupuytren’s disease fibroblasts derived from either nodule or cord: expression of alpha-smooth muscle actin and the response to stimulation by TGF-beta1. J Hand Surg [Br] 28:351–356
Bucala R, Spiegel LA, Chesney J, Hogan M, Cerami A (1994) Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair. Mol Med 1:71–81
Dave SA, Banducci DR, Graham WP 3rd, Allison GM, Ehrlich HP (2001) Differences in alpha smooth muscle actin expression between fibroblasts derived from Dupuytren’s nodules or cords. Exp Mol Pathol 71:147–155
Gabbiani G, Majno G (1972) Dupuytren’s contracture: fibroblast contraction? Am J Pathol 66:131–146
Gabbiani G, Majno G, Ryan GB (1973) The fibroblast as a contractile cell: the myofibroblast. In: Kulonen E, Pikkarainen J (eds) Biology of the fibroblast. Academic, New York, p 139
Gonalez AM, Buscaglia M, Fox R, Isacchi A, Sarmientos P et al (1992) Basic fibroblast growth factor in Dupuytren’s contracture. Am J Pathol 141:661–671
Hindman HB, Marty-Roix R, Tang JB, Jupiter JB, Simmons BP, Spector M (2003) Regulation of expression of alpha-smooth muscle actin in cells of Dupuytren’s contracture. J Bone Joint Surg Br 85:448–455
Hogemann A, Wolfhard U, Kendoff D, Board TN, Olivier LC (2009) Results of total aponeurectomy for Dupuytren’s contracture in 61 patients: a retrospective clinical study. Arch Orthop Trauma Surg 129:195–201
Howard JC, Varallo VM, Ross DC, Roth JH, Faber KJ, Alman B, Gan BS (2003) Elevated levels of beta-catenin and fibronectin in three-dimensional collagen cultures of Dupuytren’s disease cells are regulated by tension in vitro. BMC Musculoskelet Disord 4:16
Howard JC, Varallo VM, Ross DC, Faber KJ, Roth JH, Seney S, Gan BS (2004) Wound healing-associated proteins Hsp47 and fibronectin are elevated in Dupuytren’s contracture. J Surg Res 117:232–238
Hueston JT, Murrell GA (1990) Cell-controlling factors in Dupuytren’s contracture. Ann Chir Main Memb Super 9:135–137
Hurst LC, Badalamente MA (1999) Nonooperative treatment of Dupuytren’s disease. Hand Clin 15:97–107
Hurst LC, Badalamente MA, Hentz VR, Hotchkiss RN et al (2009) Injectable collagenase clostridium histolyticum for Dupuytren’s contracture. N Engl J Med 361:968–979
Kischer CW, Pindur J, Madden J, Shetlar MR, Shetlar CL (1989) Characterization of implants from Dupuytren’s contracture tissue in the nude (athymic) mouse (42859). Proc Soc Exp Biol Med 190:268–274
Kuhn MA, Payne WG, Kierney PC, Lu LL, Smith PD, Siegler K et al (2001) Cytokine manipulation of explanted Dupuytren’s affected human palmar fascia. Int J Surg Invetig 2:443–456
Larsen R, Takagishi N, Posch J (1960) The pathogenesis of Dupuytrens’ contracture. Experimental and further clinical observations. J Bone Joint Surg [Am] 42:993–1007
McFarlane RM (1974) Patterns of the diseased fascia in the fingers in Dupuytren’s contracture. Plast Reconstr Surg 54:31–44
Pagnotta A, Specchia N, Greco F (2002) Androgen receptors in Dupuytren’s contracture. J Orthop Res 20:163–168
Pan D, Watson HK, Swigart C, Thomson JG, Honig SC, Narayan D (2003) Microarray gene analysis and expression profiles of Dupuytren’s contracture. Ann Plast Surg 50:618–622
Rayan GM (1999) Clinical presentation and types of Dupuytren’s disease. Hand Clin 15:87–96
Rehman S, Salway F, Stanley JK, Ollier WE, Day P, Bayat A (2008) Molecular phenotypic descriptors of Dupuytren’s disease defined using informatics analysis of the transcriptome. J Hand Surg [Am] 33:359–372
Satish L, Laframboise WA, O’Gorman DB, Johnson S, Janto B, Gan BS, Baratz ME, Hu FZ, Post JC, Ehrlich GD, Kathju S (2008) Identification of differentially expressed genes in fibroblasts derived from patients with Dupuytren’s contracture. BMC Med Genomics 1:10
Seyhan H, Kopp J, Schultze-Mosgau S, Horch RE (2006) Increased metabolic activity of fibroblasts derived from cords compared with nodule fibroblasts sampling from patients with Dupuytren’s contracture. Plast Reconstr Surg 117:1248–1252
Shih B, Wijeratne D, Armstrong DJ, Lindau T, Day P, Bayat A (2009) Identification of biomarkers in Dupuytren’s disease by comparative analysis of fibroblasts versus tissue biopsies in disease-specific phenotypes. J Hand Surg [Am] 34:124–136
Terek RM, Jiranek WA, Goldberg MJ, Wolfe HJ, Alman BA (1995) The expression of platelet-derived growth-factor gene in Dupuytren’s contracture. J Bone Joint Surg Am 77:1–9
Tomasek JJ, Schultz RJ, Episalla CW, Newmann SA (1986) The cytoskeleton and extracellular matrix of the Dupuytren’s disease “myofibroblast”: and immunofluorescence study of a non muscle type. J Hand Surg [Am] 11:365–371
Tomasek JJ, Gabbiani G, Hinz B, Chaponnier C, Brown RA (2002) Myofibroblasts and mechano-regulation of connective tissue remodeling. Nat Rev Mol Cell Biol 2:349–363
Vande Berg JS, Gelberman RH, Rudolph R, Johnson D, Sicurello P (1984) Dupuytren’s disease: Comparative growth dynamics and morphology between cultured myofibroblasts (nodule) and fibroblasts (cord). J Orhtop Res 2:247–256
Vi L, Feng L, Zhu RD, Wu Y, Satish L, Gan BS, O’Gorman DB (2009) Periostin differentially induces proliferation, contraction and apoptosis of primary Dupuytren’s disease and adjacent palmar fascia cells. Exp Cell Res 315:3574–3586
Acknowledgments
The authors thank Allegheny-Singer Research Institute, The Pittsburgh Foundation, and Pennsylvania Department of Health for their financial support toward this study. We also thank the staff of Lab Animal Resource Facility of ASRI for their support toward this research protocol.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Satish, L. et al. (2012). Establishing an Animal Model of Dupuytren’s Contracture by Profiling Genes Associated with Fibrosis. In: Eaton, C., Seegenschmiedt, M., Bayat, A., Gabbiani, G., Werker, P., Wach, W. (eds) Dupuytren’s Disease and Related Hyperproliferative Disorders. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-22697-7_13
Download citation
DOI: https://doi.org/10.1007/978-3-642-22697-7_13
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-22696-0
Online ISBN: 978-3-642-22697-7
eBook Packages: MedicineMedicine (R0)